CD4 + FoxP3 + T regulatory cell subsets in myasthenia gravis patients
- 1 June 2017
- journal article
- Published by Elsevier in Clinical Immunology
- Vol. 179, 40-46
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Myasthenia gravis: an update for the clinicianClinical and Experimental Immunology, 2014
- Impairment of regulatory T cells in myasthenia gravis: Studies in an experimental modelAutoimmunity Reviews, 2013
- Human FoxP3+ regulatory T cells in systemic autoimmune diseasesAutoimmunity Reviews, 2011
- Naturally Occurring CD4+CD25+ Regulatory T Cells Prevent but Do Not Improve Experimental Myasthenia GravisThe Journal of Immunology, 2010
- Ex Vivo Generated Regulatory T Cells Modulate Experimental Autoimmune Myasthenia GravisThe Journal of Immunology, 2008
- Thymopoiesis, Regulatory T Cells, and TCRVβ Expression in Thymoma With and Without Myasthenia Gravis, and Modulatory Effects of Steroid TherapyJournal of Clinical Immunology, 2007
- Expression of autoimmune regulator gene (AIRE) and T regulatory cells in human thymomasClinical and Experimental Immunology, 2007
- Myasthenia gravis: past, present, and futureJournal of Clinical Investigation, 2006
- Functional defect of regulatory CD4+CD25+ T cells in the thymus of patients with autoimmune myasthenia gravisBlood, 2005
- Selective loss of regulatory T cells in thymomasAnnals of Neurology, 2004